• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2019.14102

Features of the legal and regulatory framework of rendering oncological assistance to children in Russia and abroad

[Reviews]
Andrey Reshetnikov; Margarita Gevandova; Nadejda Prisyazhnaya;

The review is devoted to a comparative analysis of the regulatory framework for oncological care for children in the Russian Federation and abroad. Despite the fact that over the past decade, many problems of providing cancer care to children in Russia have received legal regulations, additional regulation is required to maintain specialized cancer registries, to improve the organization of treatment and rehabilitation and restorative assistance for children who have had cancer. The necessary conditions determining success in overcoming the growth of infant mortality rates from malignant neoplasms are the development of an effective national strategy to combat cancer in children, solving staffing issues in pediatric oncology, an increase in the number of rehabilitation centers for children with cancer, and an increase in parents’ motivation for their children to undergo preventive check-ups.

Download

References:
1. Reshetnikov A. V. Sociologija mediciny. Rukovodstvo. M.: «Medicina», 2010. (In Russ.).
2. Reshetnikov A., Fedorova J., Prisyazhnaya N., Sotnik A., Shamshurina N., Kolesnichenko O. Health Management for Sustainable Development – 2018 Second World Conference on Smart Trends in Systems, Security and Sustainability (WorldS4), London, UK. 2018:51-56. https://doi.org/10.1109/WorldS4.2018.8611629
3. Liu L., Johnson H. L., Cousens S., Perin J., Scott S. [et al.]. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151-2161. https://doi.org/10.1016/S0140-6736(12)60560-1
4. Patton G. C., Coffey C., Cappa C., Currie D., Riley L. [et al.]. Health of the world’s adolescents: a synthesis of internationally comparable. Lancet. 2012;379:1665-1675. https://doi.org/10.1016/S0140-6736(12)60203-7
5. Ellison L. F., Pogany L. W., Mery S. Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Europ. J. Cancer. 2007;43:1967- 1975. https://doi.org/10.1016/j.ejca.2007.05.014
6. Siegel R. L., Naishadham D., Jemal A. A. Cancer statistics, 2013. CA: A Cancer J. Clin. 2012;62:10-29. 7. Ribeiro R. C., Steliarova-Foucher E., Magrath I., Lemerle J., Eden T.O. [et al.]. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol. 2008;9:721-729. https://doi.org/10.1016/S1470-2045(08)70194-3
8. Magrath I., Steliarova-Foucher E., Sidnei E., Ribeiro R., Harif M. [et al.]. Pediatric cancer in low-income and middle- income countries. Lancet Oncol. 2013;14:e104-16. https://doi.org/10.1016/S1470-2045(13)70008-1
9. Schilling F. H., Spix C., Berthold F., Erttmann R., Fehse N. [et al.]. Neuroblastoma screening at one year of age. New Engl. J. Med. 2002;346:1047-1053. https://doi.org/10.1056/NEJMoa012277
10. Smith M. A., Seibel N., Altekruse S. F., Ries L. A. G., Melbert D. L. [et al.]. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J. Clin. Oncol. 2010;28:2625-2634. https://doi.org/10.1200/JCO.2009.27.0421
11. Pui C-H., Pei D., Pappo A. S., Howard S. C., Cheng C. [et al.]. Treatment outcomes in black and white children with cancer: results from the SEER database and St. Jude Children’s Research Hospital, 1992 through 2007. J. Clin. Oncol. 2012;30:2005-2012. https://doi.org/10.1200/JCO.2011.40.8617
12. Gupta S., Rivera-Luna R., Ribeiro R., Howard S. C. Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries. PLoS Medicine. 2014;11(6):e1001656. https://doi.org/10.1371/journal.pmed.1001656
13. Childhood Cancer STAR (Survivorship, Treatment, Access, Research) Act (Public Law No: 115-180) [Еlectronic resource]. Avaiable from: https://www.cancer.gov/about-nci/legislative/recent-public-laws
14. Working for patients with rare, low-prevalence and complex diseases Share. Care. Cure. European Union, 2017.
15. European Society for Medical Oncology, European Cancer Patient Coalition, Patient Guide on Survivorship, European Society for Medical Oncology, Viganello-Lugano 2018 [Еlectronic resource]. 2018. Avaiable from: https://www.esmo.org/Patients/Patient-Guides/Patient-Guide-on-Survivorship.
16. Gupta S., Antillon F. A., Bonilla M., Fu L., Howard S. C. [et al.]. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011;117:4788-4795. https://doi.org/10.1002/cncr.26107
17. Hunger S., Reyes D., Negrin O., Pasut B., Lauzardo M. [et al.]. Decreased early mortality and increased survival with less intensive therapy for acute lymphoblastic leukemia (ALL) in the Dominican Republic. Ped. Blood Cancer. 2011;57:761.
18. Perrone F., Jommi C., Di Maio M., Gimigliano A., Gridelli C. [et al.]. The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann. Oncol. 2016;27:2224-2229. https://doi.org/10.1093/annonc/mdw433.
19. Knaul F. M., Gonzalez-Pier E., Gomez-Dantes O., Arreola- Ornelas H., Barbara-Llorens M. [et al.]. The quest for universal health coverage: acheiving social protection for all in Mexico. Lancet. 2012;380:1259-1279. https://doi.org/10.1016/S0140-6736(12)61068-X
20. Perez-Cuevas R., Doubova S. V., Zapata-Tarres M., Flores-Hernandez S., Frazier L. [et al.]. Scaling up cancer care for children without medical insurance in developing countries: the case of Mexico. Ped. Blood Cancer. 2013;60:196-203. https://doi.org/10.1002/pbc.24265
21. Ribeiro R. C. Impact of the Mexican government’s system of social protection for health, or Seguro Popular, on pediatric oncology outcomes. Ped. Blood Cancer. 2013;60:171- 172. https://doi.org/10.1002/pbc.24355
22. Philipson T., Eber M. R., Lakdawalla D. N., Corral M., Conti R. M., Goldman D. An analysis of whether higher health care spending in the United States versus Europe is «Worth It» in the case of cancer. Health Affairs. 2012;31:667-675. https://doi.org/10.1377/hlthaff.2011.1298
23. Furlow B. Expensive US cancer care: value for money? Lancet Oncol. 2012;13(5):e193. https://doi.org/10.1016/S1470-2045(12)70162-6
24. Aggarwal A., Ginsburg O. М., Fojo T. Cancer economics, policy and politics: What informs the debate? Perspectives from the EU, Canada and US. J. Cancer Policy. 2014;2(1):1-11. https://doi.org/10.1016/j.jcpo.2014.02.002
25. Luengo-Fernandez R., Leal J., Gray A., Sullivan R. Economic burden of cancer across the European Union: a population- based cost analysis. Lancet Oncol. 2013;14:1165- 1174. https://doi.org/10.1016/S1470-2045(13)70442-X
26. Legido-Quigley H., Otero-Garcia L., la Parra D., Alvarez- Dardet C., Martin-Moreno J. M., Mckee M. Will austerity cuts dismantle the Spanish healthcare system? Brit. Med. J. 2013;346:f2363. https://doi.org/10.1136/bmj.f2363
27. Sullivan R., Peppercorn J., Sikora K., Zalcberg J., Meropol N. J. [et al.]. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933-980. https://doi.org/10.1016/S1470-2045(11)70141-3
28. Pauwels K., Huys I., Casteels M., De Nys K., Simoens S. Market access of cancer drugs in European countries: improving resource allocation. Targ. Oncol. 2014;9(2): 95-110. https://doi.org/10.1007/s11523-013-0301-x
29. Richards M. Extent and causes of international variation in drug usage. Department of Health and Social Care. 2010. 30. Inequalities in Access to Cancer Drugs in Europe / Organization EC, editor. Oncopolicy Forum. – Stockholm, Sweden, 2011.
31. Folino-Gallo P., Montilla S., Bruzzone M., Martini N. Pricing and reimbursement of pharmaceuticals in Italy. Europ. J. Health Econom. 2008;9:305-310. https://doi.org/10.1007/s10198-008-0114-5
32. Le Pen С., Priol G., Lilliu H. What criteria for pharmaceuticals reimbursement? Europ. J. Health Econom. 2003;4:30-36. https://doi.org/10.1007/s10198-002-0145-2
33. Maher J., Petchey L., Greenfield D., Levitt G., Fraser M. Implementation of nationwide cancer survivorship plans: Experience from the UK. J. Cancer Pol. 2018;15(B):76-81. https://doi.org/10.1016/j.jcpo.2018.01.002
34. Gatta G., Botta L., Rossi S. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5-a population- based study. Lancet Oncol. 2014;15:35-47. https://doi.org/10.1016/S1470-2045(13)70548-5
35. De Lorenzo F., Apostolidis K., Florindia F., Makaroff L. Improving European policy to support cancer survivors. J. Cancer Pol. 2018;15(B):72-75. https://doi.org/10.1016/j.jcpo.2018.01.004
36. Cancer Delivery Plan for Wales 2016–2020: The highest standard of care for everyone with cancer. The Wales Cancer Network. 2016.
37. NHS Operational Planning and Contracting Guidance 2017–19. NHS England and NHS Improvement. 2016.
38. CCG improvement and assessment framework 2016/17. NHS England: CCG Planning and Assessment team. 2016.
39. Еvropejskie standarty lecheniya detej s onkologicheskimi zabolevaniyami. 2009. Available at: https://www.siope.eu/wp-content/uploads/2013/09/Russian.pdf. (In Russ.).
40. Epelman С. L., Epelman S. Psychosocial care in pediatric oncology. Cancer control. 2015:104-109.
41. Reshetnikov A. V., Romanov S. V., Abaeva O. P., Prisyazhnaya N. V., Smirnova G. Yu. Otnoshenie rossiyan k posmertnomu donorstvu (na primere regiona). Sociologicheskie issledovaniya. – Sociological studies. 2019;(4):70-76. (In Russ.). https://doi.org/10.31857/S013216250004587-8

Keywords: children’s oncology, legal regulation, national standards for the treatment of cancer in children